GENEVA, June 4 -- ORIC PHARMACEUTICALS, INC. (240 E. Grand Avenue, 2nd FloorSouth San Francisco, California 94080) filed a patent application (PCT/US2024/056489) for "TREATMENT OF REFRACTORY MULTIPLE MYELOMA" on Nov 19, 2024. With publication no. WO/2025/111247, the details related to the patent application was published on May 30, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MULTANI, Pratik Sharad (240 E. Grand Avenue, 2nd FloorSouth San Francisco, California 94080), MANEVAL, Edna Chow (240 E. Grand Avenue, 2nd FloorSouth San Francisco, California 94080), FRIEDMAN, Lori S. (240 E. Grand ...